Stay updated on Belantamab Mafodotin in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Belantamab Mafodotin in Myeloma Clinical Trial page.

Latest updates to the Belantamab Mafodotin in Myeloma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe history now shows a new revision entry for v3.4.2 and the government funding operating-status notice was removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check21 days agoChange DetectedA government funding lapse notice was added to the page, and the revision was updated to v3.4.1 (replacing v3.4.0).SummaryDifference0.8%

- Check28 days agoChange DetectedGlossary toggle is now visible and the diffs are color-coded (green for additions, red for deletions). The page now shows No FEAR Act Data and Revision: v3.4.0 (previously v3.3.4).SummaryDifference1%

- Check42 days agoChange DetectedThe page history shows a new revision label v3.3.4 and the removal of v3.3.3, indicating a minor site update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded Revision: v3.3.3 to the Record History. Removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the page.SummaryDifference0.2%

- Check70 days agoChange DetectedRecruitment status updated from Recruiting to Active, not recruiting as of 2025-12-15, and new sections were added (Contacts/Locations, Eligibility, Study Design, Study Status, Recruitment Status) with version 9 dated 2025-12-12, replacing the earlier Recruiting entry from 2025-01-27.SummaryDifference1.0%

Stay in the know with updates to Belantamab Mafodotin in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab Mafodotin in Myeloma Clinical Trial page.